Cite
HARVARD Citation
Zhang, T. et al. (2021). Role of aneuploid circulating tumor cells and CD31+ circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC. Molecular oncology. 15 (11), pp. 2891-2909. [Online].